BridgeMD
New treatment option for Hiv
Official title Mitigating the Impact of Stigma and Shame Among People Living With HIV and Substance Use Disorders
ClinicalTrials.gov ID: NCT05934305
What this study is testing
- What it's testing
- People living with HIV and substance use disorders (SUDs) are less likely to be virally suppressed, which can lead to HIV transmission and negative health outcomes. This hybrid type 1 study will assess the efficacy, mechanisms, as well as facilitators and barriers to implementing the MATTER intervention, a virtually delivered 5-session text-enhanced psychobehavioral intervention designed to facilitate viral suppression by addressing internalized stigma and shame as barriers to engagement in HIV care among individuals living with HIV and SUDs in two locations with different levels of HIV resources (i.e., the Boston, Massachusetts and Miami, Florida metro areas).
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- HIV+
- Meet criteria for an illicit (not solely including tobacco, cannabis, or alcohol) SUD
- Endorse internalized stigma related to HIV, substance use, sexual orientation, or gender-identity
- Either the participant reports a detectable viral load during past year OR if on oral ART, they report \ =7 days of ART in any month in the past year...
- Provide informed consent in English
You likely can't join if
- \- HIV-
See the full eligibility criteria
- HIV+
- Meet criteria for an illicit (not solely including tobacco, cannabis, or alcohol) SUD
- Endorse internalized stigma related to HIV, substance use, sexual orientation, or gender-identity
- Either the participant reports a detectable viral load during past year OR if on oral ART, they report \ =7 days of ART in any month in the past year OR for those on long acting injectable (LAI) ART, they report a...
- Provide informed consent in English
- Verbally communicate and read in English or Spanish
- Be ≥18 years old
- Provide evidence or documentation of HIV+ status
- Release HIV-related health records
- Have access to a cell phone with text capacity (study will supplement phones and plans as needed consistent with our pilot work).
- \- HIV-
The study team makes the final eligibility decision.
Where it's taking place
- Miami, Florida, United States
- Boston, Massachusetts, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Miami, Florida, United States; Boston, Massachusetts, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.